| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/02/2006 | CN1267102C Composition with anti-virus function and its preparing process |
| 08/02/2006 | CN1267101C Citron acid Azithromycin frozen-dried preparation for injection and preparation method thereof |
| 08/02/2006 | CN1267100C Medicinal composition and its preparation and use |
| 08/02/2006 | CN1267099C Medicament with protective effect against oxidative-toxic substances, particularly against cardiotoxin substances |
| 08/02/2006 | CN1267098C Usage of treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 08/02/2006 | CN1267097C Use of thiazole derivatives for the manufacture of a medicament for the treatment of chronic obstructive pulmonary disease |
| 08/02/2006 | CN1267096C Ginkgo leaf extract injection and its preparation method |
| 08/02/2006 | CN1267095C Application use of dihydromyricetrin |
| 08/02/2006 | CN1267094C Orally disintegrating tablet of safflor yellow and its preparation process |
| 08/02/2006 | CN1267093C Usage of baicalin in the preparation process of tumor resisting medicine |
| 08/02/2006 | CN1267092C Orally administered Modafinil medicine compostion |
| 08/02/2006 | CN1267091C Anti-influenza agent |
| 08/02/2006 | CN1267090C Garlicin injection emulsion and its preparing method |
| 08/02/2006 | CN1267089C Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 08/02/2006 | CN1267087C Pharmaceutical tablet |
| 08/02/2006 | CN1267085C Modifying the fatty acid composition of cell membranes of organs and tissues |
| 08/02/2006 | CN1267024C Tryptophan source from plants and uses therefor |
| 08/02/2006 | CN1267016C Composition and method |
| 08/01/2006 | USRE39221 Composition comprising a tramadol material and acetaminophen and its use |
| 08/01/2006 | USRE39219 Isolated Dna |
| 08/01/2006 | US7084301 Tamsulosin derivative |
| 08/01/2006 | US7084299 Process for producing Ibuprofen sodium dihydrate |
| 08/01/2006 | US7084282 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 08/01/2006 | US7084276 Phenyl quinolines and their use as estrogenic agents |
| 08/01/2006 | US7084270 Pyrimido compounds having antiproliferative activity |
| 08/01/2006 | US7084268 producing (+)-(1R,5S,6S)-6-[(R)-1-hydroxyethyl]-1-methyl-2-[(2S,4S)-2-[(3R)-pyrrolidine-3-yl-(R)-hydroxymethyl]pyrrolidine-4-yl]thio-1-carbapen-2-em-3-carboxylic acid monohydrochloride trihydrate crystals |
| 08/01/2006 | US7084267 for the regulation of telomerase RNA genes, including the Sp family of transcription factors |
| 08/01/2006 | US7084178 Antiamyloid phenylsulfonamides: N-cycloalkylcarboxamides derivatives |
| 08/01/2006 | US7084177 Antidiabetic agents |
| 08/01/2006 | US7084176 N-arylphenylacetamide derivatives and medicinal compositions containing the same |
| 08/01/2006 | US7084175 Animal food and method |
| 08/01/2006 | US7084174 Therapeutic treatment for reducing the incidence of bone fractures; isovaleryl L-carnitine fumarate salt |
| 08/01/2006 | US7084173 Controlling oxidation in mycardium cells |
| 08/01/2006 | US7084172 Tocopheryl retinyl succinate, tocopheryl cholecalciferyl succinate or tocopheryl ascorbyl succinate; sustained releasing active agents or vitamin by hydrolyzing with esterase contained in the skin; dermatology, cosmetics |
| 08/01/2006 | US7084171 Compounds and therapies for the prevention of vascular and non-vascular pathologies |
| 08/01/2006 | US7084170 Antitumor agents for treating a tumor of the colon or rectum in a mammal; N-[2,4-dichlorobenzoyl]-5-bromothiophene-2-sulfonamide sodium salt |
| 08/01/2006 | US7084169 Aminoalkoxyindoles and methods of use |
| 08/01/2006 | US7084168 Indoline derivatives |
| 08/01/2006 | US7084167 A secondary aminemethyl-indole derivatives, for treating diseases or physiological disorders; calcimimetic activity |
| 08/01/2006 | US7084166 Such as 1,1-di-(N-benzyl-indol-3-yl)-1-butene; for drug resistant tumors |
| 08/01/2006 | US7084165 Monoamine reuptake inhibitors for treatment of CNS disorders |
| 08/01/2006 | US7084164 Triazole derivative |
| 08/01/2006 | US7084162 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 08/01/2006 | US7084161 Method for treating inflammatory diseases or conditions |
| 08/01/2006 | US7084160 2-Amino-(imidazole, thiazole, or oxazole) derivatives; tyrosine kinase, endothelial growth factor, angiogenesis and fibroblast growth factor inhibitors; anticarcinogenic and antidiabetic agents |
| 08/01/2006 | US7084159 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 08/01/2006 | US7084158 Substituted propargylamines |
| 08/01/2006 | US7084157 Antiinflammatory agents; vision defects; antiallergens; topical applying |
| 08/01/2006 | US7084156 2-Aminoquinoline compounds |
| 08/01/2006 | US7084155 Chemokine receptor binding heterocyclic compounds |
| 08/01/2006 | US7084154 Reducing pain |
| 08/01/2006 | US7084153 Medicaments comprising steroids and a novel anticholinergic |
| 08/01/2006 | US7084152 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof |
| 08/01/2006 | US7084151 Urogenital disorders; dysmenorrhea; endometriosis; anticancer agents |
| 08/01/2006 | US7084150 pain therapy, transdermal application |
| 08/01/2006 | US7084149 Anticancer agents; antitumor agents |
| 08/01/2006 | US7084148 Analgesics; antipyretics; antiinflammatory agents |
| 08/01/2006 | US7084147 Anilinoquinazaolines as protein tyrosine kinase inhibitors |
| 08/01/2006 | US7084145 Triazole compounds useful in therapy |
| 08/01/2006 | US7084144 Sulfonyl group containing compounds and their use for the treatment of erectile dysfunction |
| 08/01/2006 | US7084143 N-(indolecarbonyl) piperazine derivatives |
| 08/01/2006 | US7084142 Anticoagulants; 2-[1S-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-3-carboxypropyl]aminocarbonyl-4-(2-methylthiazol-4-yl)methoxyquinoline; antithrombotic agents in the treatment and prevention of thrombosis |
| 08/01/2006 | US7084141 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 08/01/2006 | US7084140 Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 08/01/2006 | US7084139 Cardiovascular disorders; anticoagulants; antitumor, anticancer agents; Alzheimer's disease; Parkinson's disease |
| 08/01/2006 | US7084137 Treating glues, sizes, paper and board, textiles, leather, wood, wooden materials, paints, synthetic articles, cooling lubricants with a thiazine microbiocides; chemical synthesis from isothiocyanate; used as fungicides, batericides, miticides, insecticides, nematocides |
| 08/01/2006 | US7084136 Drug composition antagonistic to both PGD2/TXA2 receptors |
| 08/01/2006 | US7084135 Prenyl transferase inhibitors |
| 08/01/2006 | US7084133 Reaction product of carborane and vitamin d; therapy for vitamin deficiency diseases |
| 08/01/2006 | US7084132 Artemisinins with improved stability and bioavailability for therapeutic drug development and application |
| 08/01/2006 | US7084131 Method for preparing a polydispersed saccharide composition and resulting polydispersed saccharide composition |
| 08/01/2006 | US7084130 Solutions have enhanced viscosities that reduce the risk of damage to intraocular tissues during intraocular surgical procedures by reducing the turbulence of the solutions and dampening the movement of tissue fragments and air bubbles. |
| 08/01/2006 | US7084129 Antimicrobial quaternary surfactants based upon alkyl polyglycoside |
| 08/01/2006 | US7084128 Administering purinerginic receptor ligand, which is a mononucleoside polyphosphate or dinucleoside polyphosphate such as di-5'-((2'O-benzyl)adenosine)tetraphosphate; for treatment of glaucoma |
| 08/01/2006 | US7084127 C2,5′-disubstituted and N6, C2,5′-trisubstituted adenosine derivatives and their different uses |
| 08/01/2006 | US7084126 Methods and compositions for enhancing cellular function through protection of tissue components |
| 08/01/2006 | US7084125 Xylo-LNA analogues |
| 08/01/2006 | US7084124 Antidiabetic agents; insulin resistance |
| 08/01/2006 | US7084123 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 08/01/2006 | US7084122 Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents |
| 08/01/2006 | US7084117 Anticancer/tumor/scarring agents |
| 08/01/2006 | US7084116 Overactive bladder; oral administering a conotoxin |
| 08/01/2006 | US7084115 Supplying oxygen to cells; antiischemic agents; cardiovascular disorders |
| 08/01/2006 | US7084108 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 08/01/2006 | US7084107 Methods for stabilizing liquid nutritional products and products so stabilized |
| 08/01/2006 | US7084106 Reducing amyloid plaque deposits in brain; antiinflammatory agents |
| 08/01/2006 | US7083952 Nucleotide sequences coding phosphoserine phosphatase for generation of trangenic cornyeform bacterium with enhanced serine and threonine biosynthesis; for use in preparation of food, animal feeds and/or human therapeutics |
| 08/01/2006 | US7083943 Polynucleotides related to murine anti-idiotype antibody 11D10 and methods of use thereof |
| 08/01/2006 | US7083940 Polynucleotide encoding a polypeptide which has proteolytic activity for insulin like growth factor binding protein; use in diagnosis of fetal abnormalities |
| 08/01/2006 | US7083937 Characterizing purity and activity of polysaccharide preparations including glycosaminoglycans such as heparin |
| 08/01/2006 | US7083936 In aqueous solution; narrow particle size distribution |
| 08/01/2006 | US7083934 Method for detecting transferrin receptor-like proteins |
| 08/01/2006 | US7083813 Releaving symptoms using antioxidant flavonoids; reduced side effects |
| 08/01/2006 | US7083808 Controlled/modified release oral methylphenidate formulations |
| 08/01/2006 | US7083803 Ocular solutions |
| 08/01/2006 | US7083802 Using rapamycin |
| 08/01/2006 | US7083799 No-synthase inhibitors |
| 08/01/2006 | US7083781 Film forming polymers, methods of use, and devices and applications thereof |
| 08/01/2006 | US7083780 Cosmetic composition containing hydroxyethers |
| 08/01/2006 | US7083777 Induce activation lymphocytes, cytokines; response to antigens; isolated polypeptide with carrier |